Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page
- Check3 days agoChange DetectedTwo new scholarly references were added to the record, increasing the study's cited literature on dostarlimab-based therapy in endometrial cancer. The record revision was updated from v3.6.0 to v3.6.3.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study page now shows that enrollment is closed (no longer looking for participants) and adds new navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) while updating the revision note to Revision: v3.6.0.SummaryDifference0.2%

- Check24 days agoChange DetectedA new NEJM publication citation is added to the study record, listing the Dostarlimab paper's authors and DOI, and the entry shows a new revision (v3.5.5).SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a small behind-the-scenes update to the site's build or content.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page’s revision/version footer has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.